연구동향 분석

Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens

김진 남현주 정유진 이혜정 김성은 Kang Seung-Ji Park Kyung-Hwa Chang Hyun-Ha Kim Shin-Woo Chung Eun-Kyung Kim Uh Jin Jung Sook In 2022년

논문상세정보
인용/피인용
' Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Anti-retroviral agents
  • Human immunodeficiency virus
  • Integrase inhibitor
  • Lipid
  • weight gain
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
115 0

0.0%

' Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens' 의 참고문헌

  • Weight gain following initiation of antiretroviral therapy : Risk factors in randomized comparative clinical trials
    Sax PE [2020]
  • Weight gain and integrase inhibitors
    Eckard AR [2020]
  • Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
    Kuo PH [2020]
  • Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
    Bourgi K [2020]
  • Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe : comparisons with general population
    Wandeler G [2016]
  • The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population
    Bekolo CE [2014]
  • Ten-year predicted coronary heart disease risk in HIV-infected men and women
    Kaplan RC [2007]
  • Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study
    Achhra AC [2016]
  • Short communication : from wasting to obesity : initial antiretroviral therapy and weight gain in HIV-infected persons
    Lakey W [2013]
  • Screening for lipid disorders in children and adolescents : Recommendation statement
  • Predicting the risk of cardiovascular disease in HIV-infected patients : the data collection on adverse effects of anti-HIV drugs study
  • Plasma efavirenz concentrations are associated with lipid and glucose concentrations
    Sinxadi PZ [2016]
  • Obesity: preventing and managing the global epidemic. Report of a WHO consultation
  • Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021
    Ryom L [2022]
  • Long-term weight gain after initiating combination antiretroviral therapy in treatment-naïve Asian people living with human immunodeficiency virus
    Ando N [2021]
  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries : a collaborative analysis of 14 cohort studies
  • Initial antiretroviral therapy in an integrase inhibitor era : Can we do better?
    Kelly SG [2019]
  • Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents
  • Impact of physical exercises on immune function, bone mineral density, and quality of life in people living with HIV/AIDS : a systematic review with meta-analysis
    Ibeneme SC [2019]
  • Health benefits of exercise for people living with HIV : A review of the literature
    Jaggers JR [2014]
  • Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
  • Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy
    Bourgi K [2020]
  • Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy-Results from a large french multicenter cohort study
    Cotte L [2017]
  • Dyslipidemia and its treatment in HIV infection
    Grunfeld C [2010]
  • Clinical use of HIV integrase inhibitors : a systematic review and meta-analysis
    Messiaen P [2013]
  • Cardiovascular risk and dyslipidemia among persons living with HIV : a review
    Maggi P [2017]
  • Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study
  • Cardiovascular disease and use of contemporary protease inhibitors : the D : A : D international prospective multicohort study
    Ryom L [2018]
  • CROI 2021 : Metabolic and other complications of HIV infection or COVID-19
    Sarkar S [2021]
  • Brief report : weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens
    Norwood J [2017]
  • Brief report : Integrase strand transfer inhibitors are associated with lower risk of incident cardiovascular disease in people living with HIV
  • Atherosclerotic cardiovascular disease risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate
    Huhn GD [2019]